Atlas Trials

P-glypoprotein Inhibition Effect on the Pharmacokinetics of Two Tacrolimus Formulations: Prolonged and Extended-release

Clinical trial NCT04489134 · COMPLETED

Trial details

NCT number
NCT04489134
Sponsor
Rennes University Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Pharmacokinetics
Start date
2022-02-15
Primary completion
2023-05-16
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.